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Abstract
OBJECTIVE—To describe the epidemiology of complex surgical site infection (SSI) following 
commonly performed surgical procedures in community hospitals and to characterize trends of 
SSI prevalence rates over time for MRSA and other common pathogens
METHODS—We prospectively collected SSI data at 29 community hospitals in the southeastern 
United States from 2008 through 2012. We determined the overall prevalence rates of SSI for 
commonly performed procedures during this 5-year study period. For each year of the study, we 
then calculated prevalence rates of SSI stratified by causative organism. We created log-binomial 
regression models to analyze trends of SSI prevalence over time for all pathogens combined and 
specifically for MRSA.
RESULTS—A total of 3,988 complex SSIs occurred following 532,694 procedures (prevalence 
rate, 0.7 infections per 100 procedures). SSIs occurred most frequently after small bowel surgery, 
peripheral vascular bypass surgery, and colon surgery. Staphylococcus aureus was the most 
common pathogen. The prevalence rate of SSI decreased from 0.76 infections per 100 procedures 
in 2008 to 0.69 infections per 100 procedures in 2012 (prevalence rate ratio [PRR], 0.90; 95% 
confidence interval [CI], 0.82–1.00). A more substantial decrease in MRSA SSI (PRR, 0.69; 95% 
CI, 0.54–0.89) was largely responsible for this overall trend.
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CONCLUSIONS—The prevalence of MRSA SSI decreased from 2008 to 2012 in our network of 
community hospitals. This decrease in MRSA SSI prevalence led to an overall decrease in SSI 
prevalence over the study period.
Surgical site infection (SSI) is a serious complication of surgical procedures that occurs after 
approximately 2% of inpatient surgeries performed at hospitals in the United States.1 An 
estimated 157,000 SSIs occurred in US acute care hospitals in 2011,2 and 3% of patients 
with SSIs die as a result of the infection.3–5 The hospital-related cost of a single SSI has 
been estimated at $12,000–$35,000,6 and estimates of annual nationwide hospital costs of 
SSI have ranged from $3 billion to $10 billion.7 Methicillin-resistant Staphylococcus aureus 
(MRSA) is a common cause of SSI and is associated with long and expensive 
hospitalizations as well as high mortality rates.8,9
SSI is the most common type of healthcare-associated infection (HAI) in our network of 
community hospitals.10 We previously studied trends in the rates of SSI in our network and 
found that the overall prevalence rate of SSI increased from 2000 to 2005, as did the rate of 
SSI due to MRSA, which was the most common pathogen responsible for SSI.11 More 
recent data from the Centers for Disease Control and Prevention’s (CDC) National 
Healthcare Safety Network (NHSN) showed a decrease in overall SSI rates for many 
common procedures between 2008 and 2012.12 These findings are concordant with results 
of other recent studies that reported similar declines in the rate of hospital-onset invasive 
MRSA infections.13–15
Only sparse recent data are available regarding the epidemiology of SSI in community 
hospitals. Most studies describing the epidemiology of SSI have been undertaken at 
university-affiliated hospitals and other tertiary-care teaching facilities. Published studies of 
SSI in community hospitals are hampered by single-hospital retrospective designs, small 
numbers of infections, or analysis of data on rates of SSI for a limited number of procedure 
types.16–19 The objectives of this analysis were (1) to describe the epidemiology of SSI for 
commonly performed procedures in a large network of community hospitals and (2) to 
characterize the trends of SSI prevalence rates over time for MRSA and other pathogens 
frequently responsible for SSI.
METHODS
Setting
The Duke Infection Control Outreach Network (DICON) is a network of 42 community 
hospitals in 5 states in the southeastern United States.20 Community hospitals within our 
network have access to expert infection control consultation, educational services, 
benchmark data, and detailed data analysis.21 Trained and experienced infection 
preventionists prospectively enter data collected from patients undergoing 37 types of 
operative procedures22 into a database. The database contains the following information: 
type of surgical procedure; hospital; primary surgeon; patient age; procedure date and 
duration; NHSN risk index (which is calculated from the patient’s American Society of 
Anesthesiologists [ASA] classification system score, wound class, and operative duration)23; 
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and the presence or absence of postoperative SSI, including causative organism, if a 
postoperative culture was obtained and was positive.
DICON SSI surveillance methods have previously been described in detail.20,24 Potential 
SSIs were identified through review of microbiology culture results, hospital readmissions 
following surgery, clinical rounds, and questionnaires sent to surgeons regarding 
postoperative patients. Infection preventionists used NHSN criteria to categorize SSIs into 
superficial (superficial incisional) and complex (deep incisional or organ-space) SSIs.22
Analysis Plan
We analyzed 532,694 consecutive NHSN operative procedures performed at the 29 DICON 
hospitals that were members of our network from January 2008 through December 2012. In 
2013, the NHSN substantially decreased the time period of SSI surveillance following many 
procedures. Because this change in surveillance methods resulted in the exclusion of 
approximately 10% of our SSIs captured by traditional NHSN definitions,25 we excluded 
procedures performed after 2012 from our analysis.
We focused our analysis on complex SSIs because superficial SSIs are less clinically 
relevant and costly than complex SSIs.26 Furthermore, surveillance of superficial SSIs is 
difficult to standardize. However, for the procedure-specific analysis, we included total 
(complex and superficial) SSI rates to allow comparison to NHSN benchmark rates, which 
are not stratified by depth of infection.
First, we determined the overall prevalence rate of SSI during the 5-year study period and 
then stratified all collected data by procedure type, NHSN risk index, and pathogen 
responsible for infection. Then, for each year of the study from 2008 through 2012, we 
determined the prevalence rate of SSI, stratified by causative organism. We used unadjusted 
log-binomial regression to calculate annual crude prevalence rates and prevalence rate ratios 
(PRRs) for all SSIs independent of pathogen, as well as for MRSA SSI.
Next, we constructed 2 multivariate log-binomial regression models to further analyze SSI 
prevalence trends over time: one model analyzed all SSI, and the second model analyzed 
MRSA SSI only. We considered potential effect measure modifiers and confounders of the 
relationship between calendar year and SSI prevalence rate. Patient age,5,24 NHSN risk 
index,23,27 and procedure type27 are well-established risk factors for SSI. Some data suggest 
that SSI prevalence also increases for surgeons with less experience performing certain 
procedures28,29; thus, we also created a variable reflecting surgeon experience.
We defined patient age as a continuous variable. The NHSN risk index variable was defined 
as an ordinal variable; scores from 0 to 3 represented increasing levels of SSI risk. We 
defined a procedure-associated risk variable with 3 categories based upon procedure-specific 
SSI prevalence rates in the DICON network. High-risk procedures were in the highest 
quartile of SSI; low-risk procedures were in the lowest quartile of SSI; and intermediate-risk 
procedures composed the middle 2 quartiles of SSI prevalence (Table 1). Surgeon experience 
was defined as a binary variable: procedures were deemed to have been performed by an 
“experienced” surgeon if the primary surgeon performed the particular NHSN procedure 
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type >1 standard deviation more times per year than the average surgeon in the network who 
performed the procedure.
We evaluated effect measure modification of the PRRs for each of the 4 covariates by 
comparing log-binomial regression models with interaction terms to the respective reduced 
models, using likelihood ratio tests to determine significance (P < .10). A directed acyclic 
graph30 based upon findings of prior studies indicated that all 4 covariates were potential 
confounders; therefore, all covariates were initially included in both multivariate models. 
Multivariate generalized estimating equation models were fit to estimate the association 
between calendar year and SSI, adjusted for clustering of SSI at individual hospitals. We 
used likelihood ratio tests (P < .05) to determine which covariates were independent 
predictors of SSI. A backwards elimination strategy established which covariates exhibited 
meaningful confounding, changing PRR estimates by ≥10%.31
Patient and surgeon data were de-identified prior to entry into the DICON Surgical 
Database. The Duke University and University of North Carolina at Chapel Hill Institutional 
Review Boards approved this research. We maintained the data in a Microsoft Access 
database (Microsoft Corporation, Redmond, WA) and analyzed all data using SAS, version 
9.4 (SAS Institute, Cary, NC).
RESULTS
A total of 3,988 complex SSIs occurred following 532,694 consecutive procedures 
performed over the 5-year study period, giving an overall prevalence rate of 0.7 infections 
per 100 procedures (Table 2). Among the 26 procedures that were performed more than 
4,000 times during the study period, small bowel surgery had the highest prevalence rate of 
SSI (4.1 infections per 100 procedures), followed by peripheral vascular bypass surgery (3.0 
infections per 100 procedures), colon surgery (2.4 infections per 100 procedures), and 
exploratory laparotomy (1.4 infections per 100 procedures). In general, the prevalence rates 
of total (complex and superficial) SSI, stratified by risk index, were similar to prevalence 
rates reported by the National Healthcare Safety Network (NHSN).
S. aureus was the most common organism causing SSI (0.25 infections per 100 procedures) 
and was responsible for 1,357 (34%) SSIs (Table 3). MRSA and methicillin-susceptible S. 
aureus (MSSA) SSIs occurred with equal frequency: each was responsible for 17% of the 
SSIs. Escherichia coli (12%) was the most common cause of Gram-negative SSI. Overall, 
20% of SSIs were polymicrobial, and cultures were either negative or not obtained for 14% 
of SSIs.
The unadjusted prevalence rate of SSI decreased from 0.76 infections per 100 procedures in 
2008 to 0.69 infections per 100 procedures in 2012 (prevalence rate ratio [PRR], 0.90; 95% 
confidence interval [CI], 0.82–1.00) (Table 4). A decline in S. aureus SSI prevalence was 
largely responsible for the overall decrease in SSIs, and this decline in S. aureus SSI 
occurred because the rate of MRSA SSI decreased from 0.14 infections per 100 procedures 
in 2008 to 0.10 infections per 100 procedures in 2012 (PRR, 0.69; 95% CI, 0.54–0.89). In 
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comparison, the prevalence rates of SSI from other pathogens remained relatively constant 
over this 5-year period (Figure 1).
Patient age, NHSN risk index, procedure type, and surgeon experience did not exhibit 
meaningful effect measure modification of the relationship between year of surgery and SSI 
prevalence in the regression model analyzing all SSI or in the model analyzing MRSA SSI. 
All 4 covariates were independent predictors of SSI from all pathogens combined (Table 5). 
All covariates except surgeon experience were also independent predictors of MRSA SSI 
(Table 6). The adjusted PRRs of SSI for each calendar year for both models were nearly 
identical to the crude PRRs of the unadjusted models. In fact, backward elimination 
demonstrated that none of the potential confounders changed any of the point estimates in 
either model by more than 10%, and adjusting for potential clustering of SSI at particular 
hospitals had minimal effect on the estimates. The precision of the estimates from the crude 
and adjusted models were also comparable.
DISCUSSION
Our study describes a large series of consecutive surgical procedures performed over a 5-
year period at 29 community hospitals. The analysis revealed a statistically significant but 
modest decrease in the prevalence rate of SSI from all pathogens during the 5-year study 
period. This decline in rates was primarily due to a more impressive decline in the 
prevalence rate of SSI due to MRSA. Our regression analyses confirmed that neither 
influential clusters of SSI at certain hospitals nor confounding by changes in characteristics 
of surgical patients over time were responsible for the reduced rates of SSI.
Prevalence rates of SSI in our network were similar to rates of SSI previously reported by 
the NHSN for most procedures, but rates for certain common procedures and risk indices 
differed notably from NHSN benchmarks. For example, prevalence rates of SSI following 
colon surgery in our network were at least 35% lower than respective NHSN rates for each 
category of risk index.
Several factors may explain differences between SSI rates reported by our network and the 
NHSN. First, nearly 40% of hospitals in the NHSN are academic hospitals.27 As a result, the 
benchmark SSI rates reported by NHSN may not be applicable to smaller community 
hospitals.32 Also, the NHSN’s most recent comprehensive procedure-associated module 
utilized SSI data collected from 2006 through 2008; thus, rates derived from these data may 
not be consistent with current SSI rates. Our data showed recent significant declines in the 
rates of SSI due to MRSA. These findings illustrate that rates of SSI currently utilized by the 
NHSN, based on data collected 8–10 years ago, are not appropriate benchmarks for hospitals 
in 2016. Finally, NHSN surveillance reports combine data from complex and superficial 
SSIs. We think that rates of complex SSI are much more meaningful than aggregate rates of 
SSI due to complex and superficial SSI because complex SSIs are of greater clinical 
significance and are easier to consistently detect and measure.26
Hospitals in our network experienced larger reductions in prevalence rate of SSI from all 
organisms combined and specifically from MRSA when we included superficial SSI in our 
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analysis (data not shown), but the validity and implications of surveillance data including 
superficial SSIs are not clear. Thus, we believe that it is more reliable and more clinically 
relevant to evaluate and time-trend data on rates of complex SSI than to evaluate data that do 
not distinguish complex from superficial SSIs.
Our findings are consistent with the reported results in several other recently published 
national studies. These studies also reported that the prevalence of invasive MRSA 
infections has recently declined, especially among healthcare-associated infections.13–15 
However, the downward trend of the rate of SSI due to MRSA in our community hospital 
network was opposite to the trend noted in our prior study, which showed an increase in 
rates of MRSA SSI from 2000 to 2005.
Data from our study do not explain why rates of SSI caused by MRSA decreased in our 
network. We hypothesize that improved infection control practices, including specific 
interventions designed to reduce invasive MRSA infections, and national shifts in the 
genetics of S. aureus are 2 of several factors that contributed to the decreased prevalence of 
MRSA SSI.
DICON recommended 3 primary infection control practices to our member hospitals that 
may have contributed in particular to the reduction in prevalence of MRSA SSI over the 
study period. First, we recommended chlorhexidine-alcohol solutions for preoperative skin 
preparation.33–35 Second, we recommended that surgeons include intravenous vancomycin 
in the perioperative antibiotic prophylaxis regimen for selected high-risk patients, such as 
those with history of MRSA infection or colonization, recent healthcare-facility exposure, or 
planned high-risk cardiac, vascular, or implant-associated surgeries.36 Third, we 
recommended daily chlorhexidine bathing for all ICU patients.37,38 DICON did not 
recommend the routine use of MRSA preoperative screening protocols or the use of 
decolonization strategies prior to surgery. We cannot quantify the impact that these infection 
control measures had upon SSI prevalence because DICON hospitals and surgeons did not 
uniformly adopt each of our infection control recommendations. Even hospitals that made 
similar changes in infection control practices during the study period may have changed 
protocols at different times or used different methods to implement new practices.
Clonal shifts in MRSA strain types may also have contributed to the decrease in MRSA SSI 
prevalence that we observed in our network. For example, USA300 MRSA strains have 
become important causes of healthcare-associated invasive MRSA infections.14,39,40 A 
recent large study showed a significant overall decrease in hospital-onset MRSA 
bloodstream infections at US hospitals over the same time period as our study;14 however, 
rates of MRSA infection and prevalence of USA300 strains showed substantial variation 
across different geographical areas. Thus, genetic shifts associated with decreased 
prevalence of USA300 or other MRSA strain types in our region may at least partially 
explain why rates of MRSA SSI decreased in our network.
Our study has several limitations. SSIs that occur in the outpatient setting are difficult to 
detect, and our surveillance may not capture all of these infections. However, our methods 
are highly sensitive in detecting postoperative infections that require repeat surgery or 
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readmission to the hospital, and inpatient management is usually required for complex SSIs. 
Also, 14% of SSIs in our study that met NHSN SSI definitions had negative cultures or 
cultures were not performed. Complex SSIs from MRSA are typically severe infections, and 
we doubt many MRSA infections were culture-negative or not cultured; however, more 
complete data on causative pathogen might change the microbiologic epidemiology of SSI 
from less virulent or fastidious organisms described in this study. Finally, the 
generalizability of our findings to community hospitals outside of the southeastern United 
States is uncertain. Our data for MRSA SSIs correlate well with national data for invasive 
MRSA infections; however, it is possible that other trends of SSI prevalence found in our 
network were not consistent with trends experienced at hospitals in other regions.
Our data, collected from a large cohort of community hospitals, demonstrated a decrease in 
SSI prevalence, particularly in SSI due to MRSA, from 2008 to 2012. The results are 
concordant with other recent studies performed in tertiary care hospitals that have reported 
declines in invasive infections caused by MRSA. Reasons for declines in SSI prevalence are 
likely multifactorial but are still largely unknown or unproven. Further time-trended studies 
are needed to determine whether these declines will continue or reverse. Such trends are 
important because they inform perioperative prevention measures, such as screening 
protocols, antibiotic prophylaxis, and skin antisepsis practices. In the meantime, our data are 
useful benchmarks that can be used for inter-hospital comparison and to monitor trends of 
SSI prevalence at community hospitals over time.
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FIGURE 1. 
Prevalence rates of complex surgical site infection (SSI), by causative pathogen, at our 
network of 29 community hospitals from 2008 through 2012. Rates were calculated per 100 
procedures. Complex SSIs included deep-incisional and organ-space infections. S. aureus, 
Staphylococcus aureus; spp, species.
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TABLE 1
Surgical Procedures Stratified by Risk of Complex Surgical Site Infection (SSI) at Network of 29 Community 
Hospitals from 2008 through 2012
SSI Riska Procedure Typeb
High risk Liver transplant; bile duct, liver, or pancreatic surgery; small bowel surgery; peripheral vascular bypass; kidney transplant; 
spleen surgery; colon surgery; ventricular shunt; exploratory laparotomy; hip prosthesis; coronary artery bypass graft; 
craniotomy; open gallbladder surgery; spinal fusion
Intermediate risk Knee prosthesis, open appendix surgery, open reduction of fracture, abdominal hysterectomy, laparoscopic appendix 
surgery, limb amputation, other joint prosthesis (not hip or knee prosthesis), cardiac surgery, gastric surgery, laminectomy, 
herniorrhaphy, breast surgery, abdominal aortic aneurysm repair, skin graft, kidney surgery, vaginal hysterectomy
Low risk Thoracic surgery, Cesarean section, pacemaker surgery, laparoscopic gallbladder surgery, carotid endarterectomy, 
prostatectomy, thyroid-parathyroid surgery
NOTE. Complex SSIs included deep-incisional and organ-space infections.
a
High-risk procedures were in the highest quartile of SSI prevalence in the Duke Infection Control Outreach Network; low-risk procedures were in 
the lowest quartile of SSI prevalence; and intermediate-risk procedures composed the middle 2 quartiles of SSI prevalence.
b
Procedure types in each risk category are listed in descending order of complex SSI prevalence rate.
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TABLE 3
Most Common Organisms Causing Complex Surgical Site Infections (SSI) at Network of 29 Community 
Hospitals from 2008 through 2012
Organism No. (%)of SSIs (n =3,988) Prevalence Rate, Complex SSI
Bacteria
 Staphylococcus aureus 1,357 (34) 0.25
 MSSA 683 (17) 0.13
 MRSA 674 (17) 0.13
 Escherichia coli 482 (12) 0.09
 Enterococcus spp. 467 (12) 0.09
 Coagulase-negative staphylococci 340 (9) 0.06
 Klebsiella spp. 246 (6) 0.05
 Streptococcus spp. 242 (6) 0.05
 Pseudomonas aeruginosa 168 (4) 0.03
 Enterobacter spp. 161 (4) 0.03
Other
 Fungi 121 (3) 0.02
 Polymicrobiala 787 (20) 0.15
 No pathogen identifiedb 566 (14) 0.11
NOTE. Rates were calculated per 100 procedures. Complex SSIs included deep-incisional and organ-space infections. MSSA, methicillin-
susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; spp, species.
a
Polymicrobial infections were also included in individual SSI counts for each organism isolated.
bNegative cultures or no cultures taken.
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TABLE 5
Results of Multivariate Analyses Determining Independent Predictors of Complex Surgical Site Infection 
(SSI) (All Pathogens) at Network of 29 Community Hospitals from 2008 through 2012
Independent Predictor Prevalence Rate Ratio (95% CI)
Year of procedurea
 2008 1.00
 2009 1.03 (0.94–1.12)
 2010 0.97 (0.87–1.09)
 2011 0.98 (0.87–1.11)
 2012 0.89 (0.80–1.00)
Ageb
 25 year increase in age 1.09 (1.02–1.17)
NHSN risk indexb
 1 category increase in risk index 1.89 (1.71–2.09)
Procedure typec
 Intermediate-risk procedure 1.00
 High-risk procedure 1.85 (1.67–2.06)
 Low-risk procedure 0.36 (0.29–0.45)
Surgeon experienced
 High experience level 1.00
 Low experience level 1.09 (1.00–1.19)
NOTE. Complex SSIs included deep-incisional and organ-space infections. Generalized estimating equation models were fit to adjust for clustering 
of SSI at individual hospitals. Prevalence rate ratios were individually adjusted for potential confounders based upon directed acyclic graphs.30 CI, 
confidence interval; NHSN, National Healthcare Safety Network.
aAdjusted for age, NHSN risk index, procedure type, and surgeon experience.
bAdjusted for calendar year, procedure type, and surgeon experience.
cAdjusted for age, calendar year, NHSN risk index, and surgeon experience. High-risk procedures were in the highest quartile of SSI prevalence in 
the Duke Infection Control Outreach Network; low-risk procedures were in the lowest quartile of SSI prevalence; and intermediate-risk procedures 
composed the middle 2 quartiles of SSI prevalence.
dAdjusted for age, calendar year, NHSN risk index, and procedure type. A procedure performed by a surgeon with a high level of experience was 
performed by a surgeon who performed the particular NHSN procedure >1 SD more times than the average surgeon in the network who performed 
the procedure. Otherwise, the procedure was considered to have been performed by a surgeon with a low level of experience.
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TABLE 6
Results of Multivariate Analyses Determining Independent Predictors of Complex MRSA Surgical Site 
Infection (SSI) at Network of 29 Community Hospitals from 2008 through 2012
Independent Predictor Prevalence Rate Ratio (95% CI)
Year of procedurea
 2008 1.00
 2009 0.84 (0.66–1.08)
 2010 0.92 (0.69–1.22)
 2011 0.90 (0.75–1.09)
 2012 0.69 (0.53–0.89)
Ageb
 25 year increase in age 1.60 (1.37–1.86)
NHSN risk indexb
 1 category increase in risk index 2.06 (1.87–2.27)
Procedure typec
 Intermediate-risk procedure 1.00
 High-risk procedure 1.62 (1.38–1.90)
 Low-risk procedure 0.25 (0.18–0.35)
NOTE. Complex SSIs included deep-incisional and organ-space infections. Generalized estimating equation models were fit to adjust for clustering 
of SSI at individual hospitals. Prevalence rate ratios were individually adjusted for potential confounders based upon directed acyclic graphs.30
CI, confidence interval; NHSN, National Healthcare Safety Network.
aAdjusted for age, NHSN risk index, and procedure type.
bAdjusted for calendar year and procedure type.
cAdjusted for age, calendar year, and NHSN risk index. High-risk procedures were in the highest quartile of SSI prevalence in the Duke Infection 
Control Outreach Network; low-risk procedures were in the lowest quartile of SSI prevalence; and intermediate-risk procedures comprised the 
middle 2 quartiles of SSI prevalence.
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